Luckwel Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$436,013 over the previous period. Total operating expenses were $434,977.
Profit Margin
| 2014 | 0 | -224.60K | |
|---|---|---|---|
| 2015 | 950 | -264.15K | -27805.79% |
| 2016 | 44 | -420.72K | -956200% |
| 2017 | -1.69K | -510.70K | 30077.03% |
| 2018 | 295 | -537.08K | -182063.73% |
| 2019 | 5 | -622.52K | -12450520% |
| 2020 | 0 | -536.43K | |
| 2021 | 0 | -436.01K |
LWEL Income Statement (2014 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 5 | 295 | -1.69K | 44 | 950 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 5 | 295 | -1.69K | 44 | 950 | 0 |
Operating exp. | ||||||||
Research and development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 434.97K | 536.43K | 622.53K | 533.26K | 450.79K | 420.77K | 265.10K | 224.60K |
Operating income | -434.97K | -536.43K | -622.53K | -533.26K | -450.79K | -420.77K | -265.10K | -224.60K |
Other income (expenses), net | -1.03K | -13.39K | 5 | -3.82K | 0 | 44 | 949 | 0 |
Income before tax | -436.01K | -536.43K | -622.52K | -537.08K | -510.70K | -420.72K | -264.15K | -224.60K |
Income tax expense | 0 | 0 | 0 | 0 | 0 | 44 | 950 | 0 |
Net income | -436.01K | -536.43K | -622.52K | -537.08K | -510.70K | -420.72K | -264.15K | -224.60K |
Earnings per share | ||||||||
Basic EPS | -0.00 | -0.00 | -0.00 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
Diluted EPS | -0.00 | -0.00 | -0.00 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |